15-Deoxyspergualin produces inhibition of lymphokine-activated killer cell activity.
Thomas
F
F
Department of Surgery, East Carolina University School of Medicine, Greenville, NC 27858.
Matthews
C
C
Pittman
K
K
Thomas
J
J
D000818:Animals; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007376:Interleukin-2 / Q000494:pharmacology*; D015979:Killer Cells, Lymphokine-Activated / Q000187:drug effects / Q000276:immunology*; D051379:Mice; D011994:Recombinant Proteins / Q000494:pharmacology
D006146:Guanidines; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D011994:Recombinant Proteins; C037258:gusperimus